Perrigo Co. Plc (PRGO)
14.30
-0.19
(-1.31%)
USD |
NYSE |
Sep 03, 12:54
Perrigo Research and Development Expense (Annual) : 95.40M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 95.40M |
| December 31, 2024 | 112.20M |
| December 31, 2023 | 122.50M |
| December 31, 2022 | 123.10M |
| December 31, 2021 | 122.00M |
| December 31, 2020 | 121.70M |
| December 31, 2019 | 187.40M |
| December 31, 2018 | 218.60M |
| December 31, 2017 | 155.00M |
| December 31, 2016 | 184.00M |
| December 31, 2015 | 176.40M |
| June 30, 2014 | 152.50M |
| June 30, 2013 | 115.20M |
| June 30, 2012 | 105.77M |
| June 30, 2011 | 89.25M |
| June 30, 2010 | 82.51M |
| June 30, 2009 | 77.92M |
| Date | Value |
|---|---|
| June 30, 2008 | 72.19M |
| June 30, 2007 | 66.48M |
| June 30, 2006 | 52.29M |
| June 30, 2005 | 38.42M |
| June 30, 2004 | 27.72M |
| June 30, 2003 | 23.32M |
| June 30, 2002 | 19.89M |
| June 30, 2001 | 17.63M |
| June 30, 2000 | 16.31M |
| June 30, 1999 | 14.87M |
| June 30, 1998 | 15.94M |
| June 30, 1997 | 13.65M |
| June 30, 1996 | 10.44M |
| June 30, 1995 | 8.679M |
| June 30, 1994 | 6.233M |
| June 30, 1993 | 5.034M |
| June 30, 1992 | 3.373M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Avadel Pharmaceuticals Plc | -- |
| Jazz Pharmaceuticals Plc | 782.74M |
| GH Research Plc | 38.73M |
| Cosmo NV | 36.21M |
| Viatris, Inc. | 952.50M |